Interferon Signature in Anti-CTLA-4 and Anti-PD-1/PD-L1-Treated Cancer Patients Compared With Systemic Autoimmune Disease Patients

Clinical trial NCT07249060 · RECRUITING

Trial details

NCT number: NCT07249060
Sponsor: Hospital Universitario Araba
Status: RECRUITING
Study type: OBSERVATIONAL

Immune-Related Adverse Events Lupus Erythematosus, Systemic Sjogren Syndrome Systemic Sclerosis (SSc)Inflammatory Myopathies Solid Tumors

Start date: 2024-01-08
Primary completion: 2026-12-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.